Advertisement · 728 × 90
#
Hashtag
#ulonivirine
Advertisement · 728 × 90
i-Base graphic for IAS 2025. The main text reads: Once-weekly oral ART. New research that might make HIV meds even easier to take. At the top is i-Base’s website address: I hyphen base dot info. In the bottom left it says: HIV treatment bulletin. In the bottom right is a white box, containing the words: IAS 2025. 13th to 17th July. Above this is a spiral next to the red AIDS ribbon. There are horizontal strips of the IAS 2025 signature graphics at the top and bottom of the image. They are made up of squares, each containing its own unique pattern based on traditional Rwandan art. The colours used in the image are red, black, white and grey.

i-Base graphic for IAS 2025. The main text reads: Once-weekly oral ART. New research that might make HIV meds even easier to take. At the top is i-Base’s website address: I hyphen base dot info. In the bottom left it says: HIV treatment bulletin. In the bottom right is a white box, containing the words: IAS 2025. 13th to 17th July. Above this is a spiral next to the red AIDS ribbon. There are horizontal strips of the IAS 2025 signature graphics at the top and bottom of the image. They are made up of squares, each containing its own unique pattern based on traditional Rwandan art. The colours used in the image are red, black, white and grey.

24-week phase 2 results of once-weekly oral ART with #ulonivirine + #islatravir, plus other studies on this combination at #IAS2025:

i-base.info/htb/51965

Good efficacy and safety – with a larger phase 2b study already ongoing using 200mg ULO and 2 mg ISL doses.

#HIVsky #HIVtreatment #HIVresearch

5 5 0 0